Detalhe da pesquisa
1.
Immunosuppressive Drug-Resistant Armored T-Cell Receptor T Cells for Immune Therapy of HCC in Liver Transplant Patients.
Hepatology
; 74(1): 200-213, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33249625
2.
Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy.
Gastroenterology
; 156(6): 1862-1876.e9, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30711630
3.
Nonlytic Lymphocytes Engineered to Express Virus-Specific T-Cell Receptors Limit HBV Infection by Activating APOBEC3.
Gastroenterology
; 155(1): 180-193.e6, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29550589
4.
Hepatitis C Virus-Specific T Cell Receptor mRNA-Engineered Human T Cells: Impact of Antigen Specificity on Functional Properties.
J Virol
; 91(9)2017 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28228595
5.
T-cell therapy for chronic viral hepatitis.
Cytotherapy
; 19(11): 1317-1324, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28847469
6.
Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?
Med Microbiol Immunol
; 204(1): 87-94, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25511870
7.
Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial.
Hepatol Int
; 17(4): 850-859, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067675
8.
Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3.
J Gen Virol
; 93(Pt 2): 247-258, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22071510
9.
Immunological alterations after immunotherapy with short lived HBV-TCR T cells associates with long-term treatment response in HBV-HCC.
Hepatol Commun
; 6(4): 841-854, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34935312
10.
Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines.
J Hepatol
; 55(1): 103-10, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21145860
11.
Improving on the ability of endogenous hepatitis B core antigen to prime cytotoxic T lymphocytes.
J Infect Dis
; 201(12): 1867-79, 2010 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20446851
12.
Splice-Switching Antisense Oligonucleotides as a Targeted Intrinsic Engineering Tool for Generating Armored Redirected T Cells.
Nucleic Acid Ther
; 31(2): 145-154, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33567222
13.
Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial.
Hepatol Int
; 15(6): 1402-1412, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34850325
14.
A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B.
J Hepatol
; 52(3): 330-9, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20137825
15.
Cancer immunotherapy: targeting the difference.
J Hepatol
; 61(5): 1175-7, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24993529
16.
Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective.
J Gastroenterol Hepatol
; 23(6): 833-43, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18565018
17.
Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection.
J Clin Invest
; 127(8): 3177-3188, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28737510
18.
A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors.
JCI Insight
; 2(12)2017 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28614795
19.
Redirecting T Cell Specificity Using T Cell Receptor Messenger RNA Electroporation.
Methods Mol Biol
; 1428: 285-96, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27236807
20.
Targeted Therapy of Hepatitis B Virus-Related Hepatocellular Carcinoma: Present and Future.
Diseases
; 4(1)2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28933390